Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Soluble Aβ oligomer-induced synaptopathy: c-Jun N-terminal kinase's role.
Sclip A, Arnaboldi A, Colombo I, Veglianese P, Colombo L, Messa M, Mancini S, Cimini S, Morelli F, Antoniou X, Welker E, Salmona M, Borsello T. Sclip A, et al. Among authors: veglianese p. J Mol Cell Biol. 2013 Aug;5(4):277-9. doi: 10.1093/jmcb/mjt015. Epub 2013 Apr 18. J Mol Cell Biol. 2013. PMID: 23606726 Free article. No abstract available.
c-Jun N-terminal kinase regulates soluble Aβ oligomers and cognitive impairment in AD mouse model.
Sclip A, Antoniou X, Colombo A, Camici GG, Pozzi L, Cardinetti D, Feligioni M, Veglianese P, Bahlmann FH, Cervo L, Balducci C, Costa C, Tozzi A, Calabresi P, Forloni G, Borsello T. Sclip A, et al. Among authors: veglianese p. J Biol Chem. 2011 Dec 23;286(51):43871-43880. doi: 10.1074/jbc.M111.297515. Epub 2011 Oct 27. J Biol Chem. 2011. PMID: 22033930 Free PMC article.
A new fluorogenic peptide determines proteasome activity in single cells.
Urru SA, Veglianese P, De Luigi A, Fumagalli E, Erba E, Gonella Diaza R, Carrà A, Davoli E, Borsello T, Forloni G, Pengo N, Monzani E, Cascio P, Cenci S, Sitia R, Salmona M. Urru SA, et al. Among authors: veglianese p. J Med Chem. 2010 Oct 28;53(20):7452-60. doi: 10.1021/jm100362x. J Med Chem. 2010. PMID: 20883027 Free article.
Current options for drug delivery to the spinal cord.
Rossi F, Perale G, Papa S, Forloni G, Veglianese P. Rossi F, et al. Among authors: veglianese p. Expert Opin Drug Deliv. 2013 Mar;10(3):385-96. doi: 10.1517/17425247.2013.751372. Epub 2013 Jan 6. Expert Opin Drug Deliv. 2013. PMID: 23289716 Review.
Nanovector-mediated drug delivery for spinal cord injury treatment.
Caron I, Papa S, Rossi F, Forloni G, Veglianese P. Caron I, et al. Among authors: veglianese p. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Sep-Oct;6(5):506-15. doi: 10.1002/wnan.1276. Epub 2014 May 21. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014. PMID: 24845580 Review.
Current Options for Cell Therapy in Spinal Cord Injury.
Vismara I, Papa S, Rossi F, Forloni G, Veglianese P. Vismara I, et al. Among authors: veglianese p. Trends Mol Med. 2017 Sep;23(9):831-849. doi: 10.1016/j.molmed.2017.07.005. Epub 2017 Aug 12. Trends Mol Med. 2017. PMID: 28811172 Review.
48 results